Evidence map›Paper›PMID 41585290›Full record

ArticleStroke (Hoboken, N.J.)2022

Mechanical Thrombectomy Beyond 2b Reperfusion: Should We Pursue a Higher Reperfusion Grade after Achievement of 2b?

Junpei Koge, Kanta Tanaka, Takeshi Yoshimoto, Masayuki Shiozawa, Tsuyoshi Ohta, Tetsu Satow, Hiroharu Kataoka, Masafumi Ihara, Masatoshi Koga, Kazunori Toyoda

Registry-linked trialAbstract read
In one paragraph

Article in Stroke (Hoboken, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02251665 (National Cerebral and Cardiovascular Center), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02251665 active not recruitingnot on this map

National Cerebral and Cardiovascular Center (NCVC) Stroke Registry

TypeobservationalSponsorNational Cerebral and Cardiovascular Center, JapanRan2016 to 2028Enrolled5,374ConditionsStroke, AcuteArmsNo intervention
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Junpei KogeDepartment of Cerebrovascular Medicine National Cerebral and Cardiovascular Center Suita Osaka Japan.ORCID https://orcid.org/0000-0002-9632-2164
Kanta TanakaDivision of Stroke Care Unit National Cerebral and Cardiovascular Center Suita Osaka Japan.
Takeshi YoshimotoDepartment of Neurology National Cerebral and Cardiovascular Center Suita Osaka Japan.
Masayuki ShiozawaDepartment of Cerebrovascular Medicine National Cerebral and Cardiovascular Center Suita Osaka Japan.
Tsuyoshi OhtaDepartment of Neurosurgery National Cerebral and Cardiovascular Center Suita Osaka Japan.
Tetsu SatowDepartment of Neurosurgery National Cerebral and Cardiovascular Center Suita Osaka Japan.
Hiroharu KataokaDepartment of Neurosurgery National Cerebral and Cardiovascular Center Suita Osaka Japan.
Masafumi IharaDepartment of Neurology National Cerebral and Cardiovascular Center Suita Osaka Japan.
Masatoshi KogaDepartment of Cerebrovascular Medicine National Cerebral and Cardiovascular Center Suita Osaka Japan.
Kazunori ToyodaDepartment of Cerebrovascular Medicine National Cerebral and Cardiovascular Center Suita Osaka Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Extended thrombolysis in cerebral infarction (eTICI) 2c/3 reperfusion after mechanical thrombectomy (MT) is associated with better stroke outcomes than eTICI 2b. Whether additional MT attempt after achieving eTICI 2b (beyond 2b attempt) leads to better outcomes is unknown. Methods: Consecutive patients with acute anterior circulation stroke who achieved eTICI 2b during MT were divided into 2 groups: those who further tried MT (beyond-2b group) and those without (nonbeyond-2b group). The patients who directly achieved eTICI 2c/3 without experiencing 2b (direct-2c/3 group) were also studied. The outcomes included the reperfusion status, favorable outcome (3-month modified Rankin scale score of 0-2), neurological improvement (a ≥10-point decrease of the National Institutes of Health Stroke Scale score from baseline or the score of 0) at 24 hours and symptomatic intracranial hemorrhage. Results: Of 308 patients, 50 were in the beyond-2b group, 87 in the nonbeyond-2b group, and the remaining 171 in the direct-2c/3 group. Perfusion of middle cerebral artery branches supplying the primary motor cortex was worse in the beyond-2b than the nonbeyond-2b group at the time of eTICI 2b ( Conclusions: Patients undergoing additional MT attempt after achieving eTICI 2b had numerically but not significantly more symptomatic intracranial hemorrhage and showed a similar level of functional outcome at 3 months than those who did not. When eTICI 2c/3 was finally achieved by additional attempts, functional outcome was similar with that of patients who directly achieved eTICI 2c/3 without experiencing 2b. Clinical Trial Registration Information: URL: https://www.clinicaltrials.gov. Unique identifier: NCT02251665.

Indexed as

reperfusionstrokethrombectomy

Identifiers

PMID41585290
PMCPMC12778745

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.